Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report

被引：10
作者：
Su, Jian-An
Wu, Chien-Hui [1 ]
Tsang, Hin-Yeung
机构：
[1] Chang Gung Mem Hosp, Dept Rheumatol Immunol & Allergy, Chia Yi Shen 61344, Taiwan
[2] Chang Gung Mem Hosp, Dept Psychiat, Chia Yi Shen 61344, Taiwan
来源：
GENERAL HOSPITAL PSYCHIATRY | 2007年 / 29卷 / 01期
关键词：
olanzapine-induced; agranulocytosis; neutropenia; SLE; INDUCED NEUTROPENIA; CLOZAPINE; LEUKOPENIA;
D O I：
10.1016/j.genhosppsych.2006.10.011
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Systemic lupus erythematosus (SLE) patients may have psychiatric manifestations during the illness course. Psychotropic agents are indicated in treating these symptoms. Second-generation antipsychotics, such as risperidone, olanzapine and quetiapine, have been thought to be safer than clozapine with regard to the side effect of neutropenia or agranulocytosis. We report a case of SLE who developed agranulocytosis during the treatment with olanzapine for the SLE-related psychiatric symptoms. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码：75 / 77
页数：3
相关论文
共 16 条
  • [1] Olanzapine and haloperidol: Potential for neutropenia?
    Abdullah, N
    Voronovitch, L
    Taylor, S
    Lippmann, S
    [J]. PSYCHOSOMATICS, 2003, 44 (01) : 83 - 84
  • [2] Beasley CM, 1997, J CLIN PSYCHIAT, V58, P13
  • [3] Olanzapine-induced neutropenia after clozapine-induced neutropenia
    Benedetti, F
    Cavallaro, R
    Smeraldi, E
    [J]. LANCET, 1999, 354 (9178) : 567 - 567
  • [4] A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus
    Bodani, M
    Kopelman, MD
    [J]. LUPUS, 2003, 12 (12) : 947 - 949
  • [5] Olanzapine-induced leukopenia with human leukocyte antigen profiling
    Buchman, N
    Strous, RD
    Ulman, AM
    Lerner, M
    Kotler, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (01) : 55 - 57
  • [6] Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis
    Finkel, B
    Lerner, A
    Oyffe, I
    Rudinski, D
    Sigal, M
    Weizman, A
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (03) : 133 - 135
  • [7] Olanzapine-induced neutropenia
    Gajwani, P
    Tesar, GE
    [J]. PSYCHOSOMATICS, 2000, 41 (02) : 150 - 151
  • [8] Agranulocytosis and neutropenia with typical and atypical neuroleptics
    Hong, XH
    Wang, XX
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10) : 1736 - 1737
  • [9] Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis
    Iverson, S
    Zahid, N
    Uetrecht, JP
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2002, 142 (1-2) : 175 - 199
  • [10] Dose-dependent olanzapine-associated leukopenia: three case reports
    Kodesh, A
    Finkel, B
    Lerner, AG
    Kretzmer, G
    Sigal, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (02) : 117 - 119
12